Troubleshooting from a tablet manufacturer’s perspective
I Holland to host a solutions-led seminar focusing on resolving tablet compression issues.
I Holland will educate the pharmaceutical and nutraceutical industries on common problems encountered during tablet production, by hosting a solutions-led seminar, 2-3 November 2017. The event will take a fresh approach on how to resolve renowned issues within the manufacturing process.
Having researched the issues related to tablet compression, and devised a structured programme to combat the problems, I Holland, a leading manufacturer of tablet tooling, will share their findings in a seminar designed to give an in-depth technical view on troubleshooting from a tablet manufacturer’s perspective.
Marianna D’Onghia, I Holland’s host for the event said: “The Ultimate Guide to Compression Tooling Seminar is a comprehensive 2-day event, which takes attendees through the most common problems found in modern tablet production, from sticking and picking to weight control and capping.
“The seminar is designed to highlight the most prolific problems and offer answers to each issue. It also demonstrates how to tackle elements of punch and die design, tooling specification and aftercare through a planned professional maintenance programme, all of which will help to improve output and profitability. The event will combine a practical element and demonstrate how this process works.
“Delegates will have the opportunity to visit the I Holland factory and see punch manufacture from design through to despatch of the final product. Attendees can also address specific problems to our team of experts who will be on hand to offer advice. The seminar is the perfect opportunity to discuss individual cases and gain informative feedback on how I Holland can further assist in solving tooling problems.
“I Holland hold seminars several times a year to help to educate the industry on how they can solve common tablet production problems with better foresight and understanding of the potential causes, whilst offering practical solutions which will result in saving not just time, but also money. The seminar is an effective platform in which to share I Holland’s 70 years of experience and expertise in the production process within tablet manufacturing.“
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.